Synergistic interaction between valproate and lamotrigine against seizures induced by 4-aminopyridine and pentylenetetrazole in mice

被引:19
作者
Cuadrado, A [1 ]
de las Cuevas, I [1 ]
Valdizán, EM [1 ]
Armijo, JA [1 ]
机构
[1] Univ Cantabria, Sch Med, Marques de Valdecilla Univ Hosp, Dept Physiol & Pharmacol,Clin Pharmacol Serv, E-39008 Santander, Spain
关键词
valproate; lamotrigine; pentylenetetrazole; 4-aminopyridine; anticonvulsant; drug interactions;
D O I
10.1016/S0014-2999(02)02341-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We compared the effects of adding a non-protective dose of valproate to increasing doses of lamotrigine with those of monotherapy and vice versa in CD I mice. Anticonvulsant effects were evaluated against seizures induced by both 4-aminopyridine and pentylenetetrazole, and neurotoxic effects were evaluated by the rotarod test. Changes in anticonvulsants, gamma-aminobutyric acid (GABA) and glutamate concentrations in the whole brain were also assessed. Lamotrigine increased the potency ratio of valproate against 4-aminopyridine and pentylenetetrazole but not on rotarod, the protective index being increased from 1.1 to 2.4 against 4-aminopyridine and from 1.9 to 3.8 against pentylenetetrazole, without changes in brain valproate, and with a significant increase in brain GABA. Valproate increased the potency ratio of lamotrigine against 4-aminopyridine but not on rotarod, the protective index being increased from 4.4 to 7.3; valproate also increased brain lamotrigine (but only at low doses), brain GABA and brain glutamate. In conclusion, non-protective doses of lamotrigine increased the therapeutic index of valproate and vice versa, and these effects appeared to be pharmacodynamic. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:43 / 52
页数:10
相关论文
共 39 条
[1]  
Arzimanoglou A, 2001, REV NEUROL-FRANCE, V157, P525
[2]   ANTICONVULSANT POTENCY AND NEUROTOXICITY OF VALPROATE ALONE AND IN COMBINATION WITH CARBAMAZEPINE OR PHENOBARBITAL [J].
BOURGEOIS, BFD .
CLINICAL NEUROPHARMACOLOGY, 1988, 11 (04) :348-359
[3]  
BOURGEOIS BFD, 1988, J PHARMACOL EXP THER, V247, P1128
[4]   Lamotrigine substitution study: Evidence for synergism with sodium valproate? [J].
Brodie, MJ ;
Yuen, AWC .
EPILEPSY RESEARCH, 1997, 26 (03) :423-432
[5]   PHARMACODYNAMIC INTERACTIONS BETWEEN PHENYTOIN AND VALPROATE - INDIVIDUAL AND COMBINED ANTIEPILEPTIC AND NEUROTOXIC ACTIONS IN MICE [J].
CHEZ, MG ;
BOURGEOIS, BFD ;
PIPPENGER, CE ;
KNOWLES, WD .
CLINICAL NEUROPHARMACOLOGY, 1994, 17 (01) :32-37
[6]   KAINIC ACID AND 4-AMINOPYRIDINE SEIZURE MODELS IN MICE - EVALUATION OF EFFICACY OF ANTIEPILEPTIC AGENTS AND CALCIUM-ANTAGONISTS [J].
CRAMER, CL ;
STAGNITTO, ML ;
KNOWLES, MA ;
PALMER, GC .
LIFE SCIENCES, 1994, 54 (16) :PL271-PL275
[7]   VALPROIC ACID - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL EFFICACY IN EPILEPSY [J].
DAVIS, R ;
PETERS, DH ;
MCTAVISH, D .
DRUGS, 1994, 47 (02) :332-372
[8]   Lamotrigine potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice [J].
DeSarro, G ;
Nava, F ;
Aguglia, U ;
DeSarro, A .
NEUROPHARMACOLOGY, 1996, 35 (02) :153-158
[9]   A NOTE ON A SIMPLE APPARATUS FOR DETECTING NEUROLOGICAL DEFICIT IN RATS AND MICE [J].
DUNHAM, NW ;
MIYA, TS .
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1957, 46 (03) :208-209
[10]  
Fariello Ruggero G., 1995, P581